• UCLA Easton Center Wide-Team


  • Alzheimer's Association's 2024 Alzheimer's Disease Facts and Figures


    Alzheimer's begins 20 years or more before memory loss and other symptoms develop.(report and image courtesy of Alzheimer's Association ®)

  • Easton Center’s Spring 2024 Newsletter features Dr. Sánchez López’s answers to common questions about lecanemab and the ELHA Lab, bridging science and the Latino communities in LA County.
    Spring 2024 Newsletter

    Easton Center’s Spring 2024 Newsletter features Dr. Sánchez López’s answers to common questions about lecanemab and the ELHA Lab, bridging science and the Latino communities in Los Angeles County.

  • 2023 Turken Research Award and Symposium Group photo

    Congratulations to Dr. Kacie Deters, Assistant Professor of Integrative Biology and Physiology at UCLA, for receiving the 2023 Turken Research Award! Photo: Dr. Saver, Ms. Cooper Ortner (AlzLA), Dr. Deters, Ms. Devermont (Turken donor), and Dr. Hinman.

  • UCLA Health and the Easton Center members at the Alzheimer's Los Angeles' 3rd Annual Music Festival

    UCLA Health and the Easton Center members were proud to support Alzheimer’s Los Angeles’ 3rd Annual Making Memories Festival on Sunday, November 12, 2023.

  • Easton Center members at the Alzheimer's Association, Walk to End Alzheimer's

    The UCLA Easton Center Team joined the Alzheimer’s Association’s Walk to End Alzheimer’s in Santa Monica on Sunday, October 22, 2023, to provide information and show support to the many families and caregivers affected by Alzheimer’s disease.

  • Dr. Keith Vossel's interview on Fox 11 News-7-7-2023

    Watch Dr. Keith Vossel's live interview with Marla Tellez on July 7th, FOX 11 News LA, about the FDA’s full approval of Alzheimer’s drug, Lecanemab, who is eligible, the treatment benefits, side effects, and expected costs with Medicare coverage.

  • Dr. Keith Vossel's interview on KCAL-LA Morning & Afternoon News

    Watch Dr. Vossel’s live interview with KCAL-LA Evening & Morning News about the benefits of the treatment, possible side effects, and expected out-of-pocket costs with CMS coverage for patients eligible for Leqembi, a fully FDA-approved Alzheimer’s drug

  • Easton Center Kagan Clinical Trials Alzheimer's Disease Treatment Development Program


    Clinical studies are the primary way that researchers/scientists/physicians find out if a promising treatment is safe and effective for patients or if some treatments are more effective than others.

The Mary S. Easton Center for Alzheimer’s Research and Care at UCLA (UCLA Easton Center) is committed to equity, diversity, inclusion, and belonging, in our research, care, and support of people, families, and communities living with Alzheimer’s disease and related disorders. Alzheimer’s disease affects our growing aging population, projected to increase exponentially to 13 million in the US by 2050. The Easton Center is fully committed to serving all people, their families, and communities impacted by this disease.

Learn More

Donate to help fight Alzheimer's disease!

Make a Gift


stethoscope and table on white background


If you or a loved one is experiencing from memory problems, there are many reasons to be assessed by a physician who specializes in this area.

Learn More
UCLA Mary S. Easton Center for Alzheimer's Research and Care - Caregiver Support Groups


We have 9 Caregiver Support Groups for family caregivers seeking a supportive environment.

Learn More
diversity inner painting of faces


Our resource library comprises information on patient care and well-being of caregivers of persons with Alzheimer's and related dementias.

Learn More

Why Participate?

  • Have regular contact with the research team.
  • Receive state-of-the-art care and talk with experts who have practical experience.
  • Find new ways to cope with present challenges.
  • Learn new insights into what to expect in the future.
  • Make valuable contributions to the knowledge that will help future patients.


Clinical Trials

Participating in clinical trials help gains crucial discoveries from a new treatment for scientists to advance their research.


Learn More

Doctor viewing the patient chart on a tablet


Observational Research Studies

Researchers collect data from observational studies to address the importance of risk factors that links to dementia and Alzheimer’s disease.

Learn More

purple ribbon to support brain donation for research


Brain Donation

This program refers to brain donation through autopsy. Neuropathological studies have produced some of the most dramatic breakthroughs in understanding and diagnosing Alzheimer’s disease.

Learn More

Events + Calendar



Coronavirus (COVID-19)

Helpful Information

Quarterly Newsletter Sign-Up Form

Join Today!